Lumbar Disc Herniation with Sacroiliac Joint Dysfunction Complicated by Lumbosacral Radiculopathy and Functional Impairment
Conditions
Interventions
Experimental Group: Platelet-rich plasma (PRP) combined with sodium hyaluronate (HA) therapy.:Treatment with Platelet-Rich Plasma (PRP) combined with Sodium Hyaluronate (HA).
Control Group: Conventional radiofrequency ablation (RFA) therapy.:Standard RFA therapy
Sponsors
Songyang County Hospital of traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1.Meet the diagnostic criteria for LDH (lumbar disc herniation) combined with sacroiliac joint dysfunction. 2.Age between 18 and 60 years. 3.Able to complete the treatment according to the study plan. 4.Signed informed consent form;
Exclusion criteria
Exclusion criteria: 1.Pregnant or lactating women. 2.Patients with imaging evidence of lumbar vertebral bone destruction (e.g., tumors, tuberculosis, etc.). 3.Patients with comorbid conditions such as lumbar spondylolisthesis, osteoporosis, or spinal stenosis. 4.Patients with severe primary diseases, such as liver, kidney, heart, cerebrovascular, or hematopoietic system disorders. 5.Patients for whom the efficacy of previously received Chinese or Western medications for LDH combined with sacroiliac joint dysfunction cannot be determined, or those with incomplete data that may affect efficacy evaluation. 6.Patients unwilling to participate in the study or who voluntarily withdraw during the treatment process. 7.Patients receiving other concurrent treatments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analog Scale (VAS) for pain intensity(VAS);Modified Japanese Orthopaedic Association (M-JOA) Score for Low Back Pain;Orlando Pelvic Outcome Score;Pelvic Deviation Value (PD Value); | — |
Countries
China
Contacts
Public ContactQue Qihong
Songyang County Hospital of traditional Chinese Medicine
Outcome results
None listed